Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$4.8B
207M shares
52-week range
$11.63 – $23.87
95% from low
Sector
HOSPITAL & MEDICAL SERVICE PLANS
Exchange
NASDAQ
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $757.0M | $959.2M | $1.17B | $1.43B | $1.82B | $2.70B | $3.95B |
| Cost of revenue | $661.4M | $793.0M | $1.04B | $1.25B | $1.62B | $2.41B | $3.46B |
| Gross profit | $95.6M | $166.2M | $128.7M | $184.3M | $201.0M | $296.7M | $488.6M |
| Gross margin | 12.6% | 17.3% | 11.0% | 12.8% | 11.0% | 11.0% | 12.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$29.5M | −$5.3M | −$178.1M | −$128.6M | −$127.8M | −$101.6M | $14.8M |
| EBITDA | −$13.3M | $9.5M | −$161.8M | −$113.5M | −$105.3M | −$77.4M | $45.3M |
| Net income | −$44.7M | −$22.9M | −$195.3M | −$149.5M | −$148.0M | −$128.0M | −$724.0K |
| Net margin | -5.9% | -2.4% | -16.7% | -10.4% | -8.1% | -4.7% | -0.0% |
| EPS (diluted) | -0.29 | -0.12 | -1.14 | -0.83 | -0.79 | -0.67 | -0.00 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $5.2B | $0.19 | $0.13–$0.23 | 6 |
| 2027 | $6.5B | $0.43 | $0.36–$0.54 | 6 |
| 2028 | $8.1B | $0.74 | $0.58–$0.85 | 6 |
| 2029 | $10.8B | $1.20 | $1.17–$1.24 | 4 |
Forward consensus · source: Financial Modeling Prep
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
www.alignmenthealth.comNo one on the platform currently holds ALHC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 2,903,100 | $51.2M |
No one on the platform has traded ALHC yet.
| $3.7B |
| — |
| MIRMMirum Pharmaceuticals, Inc. | $123.44 | -0.27% | $6.2B | — |
| NVSTEnvista Holdings Corp | $26.89 | -0.26% | $4.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.5× sales vs its 0.8× historical median P/S.
Fair value ≈ $12.59 · price $23.26 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$CLOV A reminder our EV/Rev is still in line with $ALHC (1.09 Vs 1.01) Our current price is justified on being a fast growing MA insurer alone Any SAAS news would be pure upside at this point
View on StockTwits ↗These $ALHC calls are now $6.00 from $0.79.. but they did take profits at $3.18 2 days ago.
View on StockTwits ↗$CLOV What's funny is despite all the news, $ALHC is still ahead of us on the week despite them having no news I think that's a sign that there is still headroom here for us to catch up at the very least...
View on StockTwits ↗$ALHC darn it; I didn’t think it would move until later this summer
View on StockTwits ↗$ALHC a lot can change in a weeks time
View on StockTwits ↗$ALHC and looks like they did take profits today on this 20%+ move in the stock. 3,000 of the calls closed for $3.18/avg so +300% for them
View on StockTwits ↗$ALHC if you played this 👏 Stock up 22% today at the GS conference. Calls up 400%
View on StockTwits ↗$ALHC $18.50 next target https://www.trade-ideas.com/share.php?code=LGv4pyCwRhPgLsNF2NFX6xXWRPNAZEsO
View on StockTwits ↗$ALHC +3.5% in this ugly tape. Calls up to about $1.20.
View on StockTwits ↗$ALHC call buyer into the close with IV spiking. Presenting at the GS conference next week.
View on StockTwits ↗$ALHC Dirty Dealings in Cali? Hmm?
View on StockTwits ↗$CLOV weird moves across the MA sector today... Why is $ALHC down 10% on no news? Why is $HUM up 8% on reaffirming guidance Clover with much bigger news seems coiled for further breakout...
View on StockTwits ↗$ALHC Share Price: $15.98 Contract Selected: Nov 20, 2026 $20 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.59 – $1.95 Potential Upside: 77% ROI Time to Expiration: 177 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.